FRA:IUI1 - Deutsche Boerse Ag - US46120E6023 - Common Stock - Currency: EUR
FRA:IUI1 (3/7/2025, 7:00:00 PM)
467.85
-46.55 (-9.05%)
The current stock price of IUI1.DE is 467.85 EUR. In the past month the price decreased by -17.68%. In the past year, price increased by 29.62%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 28.95 | 217.38B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 79.29 | 192.03B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.01 | 133.56B | ||
2M6.DE | MEDTRONIC PLC | 17.45 | 110.81B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.31 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.43 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.18 | 28.81B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 18.17 | 23.74B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 18.14 | 23.71B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 18.06 | 23.59B | ||
BIM.PA | BIOMERIEUX | 33.32 | 13.65B |
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 13,676 full-time employees. The company went IPO on 2000-06-13. The firm's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. The company also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. The company extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 13676
Company Website: https://www.intuitivesurgical.com/
Investor Relations: https://isrg.intuitive.com
Phone: 14085232100
The current stock price of IUI1.DE is 467.85 EUR. The price decreased by -9.05% in the last trading session.
The exchange symbol of INTUITIVE SURGICAL INC is IUI1 and it is listed on the Deutsche Boerse Ag exchange.
IUI1.DE stock is listed on the Deutsche Boerse Ag exchange.
39 analysts have analysed IUI1.DE and the average price target is 613.78 EUR. This implies a price increase of 31.19% is expected in the next year compared to the current price of 467.85. Check the INTUITIVE SURGICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INTUITIVE SURGICAL INC (IUI1.DE) has a market capitalization of 166.86B EUR. This makes IUI1.DE a Large Cap stock.
INTUITIVE SURGICAL INC (IUI1.DE) currently has 13676 employees.
INTUITIVE SURGICAL INC (IUI1.DE) has a resistance level at 589.3. Check the full technical report for a detailed analysis of IUI1.DE support and resistance levels.
The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 17.3% in the next year. Check the estimates tab for more information on the IUI1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IUI1.DE does not pay a dividend.
INTUITIVE SURGICAL INC (IUI1.DE) will report earnings on 2025-04-16, after the market close.
The PE ratio for INTUITIVE SURGICAL INC (IUI1.DE) is 68.9. This is based on the reported non-GAAP earnings per share of 6.79 and the current share price of 467.85 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IUI1.DE.
ChartMill assigns a technical rating of 2 / 10 to IUI1.DE. When comparing the yearly performance of all stocks, IUI1.DE is one of the better performing stocks in the market, outperforming 75.96% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to IUI1.DE. IUI1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 6.79. The EPS increased by 28.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 27.81% | ||
ROA | 12.39% | ||
ROE | 14.05% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 79% to IUI1.DE. The Buy consensus is the average rating of analysts ratings from 39 analysts.
For the next year, analysts expect an EPS growth of 12.03% and a revenue growth 17.3% for IUI1.DE